Current:Home > BackCan AI detect skin cancer? FDA authorizes use of device to help doctors identify suspicious moles.-DB Wealth Institute B2 Expert Reviews
Can AI detect skin cancer? FDA authorizes use of device to help doctors identify suspicious moles.
View Date:2024-12-23 14:15:23
The Food and Drug Administration has authorized the first artificial intelligence-powered medical device to help doctors detect the most common forms of skin cancer in patients.
The technology, from Miami-based medical device maker DermaSensor, is used to further evaluate lesions that doctors have already flagged as suspicious and is not meant to be used as a screening tool, according to the FDA.
More specifically, the non-invasive, handheld device uses AI-powered spectroscopy tech to assess cellular and below-the-skin's-surface characteristics of lesions on patients. The device, also called DermaSensor, provides real-time results based on an AI algorithm that is trained on data related to more than 4,000 malignant and benign lesions, according to the company. It then delivers a "spectral similarity score" to known cases in order to complement a physician's own assessment of a mole or lesion.
DermaSensor says the device gives primary care physicians, dermatologists and other doctors a high-tech way to evaluate moles for skin cancer beyond simply beyond examining a patient with the naked eye or through a magnifying glass.
"The device should be used in conjunction with the totality of clinically relevant information from the clinical assessment, including visual analysis of the lesion, by physicians who are not dermatologists," the FDA said, noting that DermaSensor is for use in patients ages 40 and up.
Here's how DermaSensor works, according to the company.
1. A doctor identifies a potentially cancerous lesion on a patient.
2. The wireless device is pressed against the lesion to record it.
3. DermaSensor scans the lesion.
4. A proprietary algorithm analyzes spectral data and delivers an assessment in real-time.
5. An "Investigate Further" result suggests a specialist should examine the lesion.
6. A "Monitor" result suggests no further evaluation is immediately necessary.
"We are entering the golden age of predictive and generative artificial intelligence in health care, and these capabilities are being paired with novel types of technology, like spectroscopy and genetic sequencing, to optimize disease detection and care," Cody Simmons, co-founder and CEO of DermaSensor, in a statement announcing the FDA clearance.
In addition to helping spot melanoma, which is the most deadly form of skin cancer, the device can also assess moles for basal cell carcinoma and squamous cell carcinoma.
One in five Americans will have developed a form of skin cancer by the age of 70, according to the American Academy of Dermatology, which puts the cumulative cost of treatment in the U.S. at more than $8 billion. Most skin cancers are curable if detected early.
In approving the DermaSensor device, the FDA is requiring that the company conduct additional validation testing in patients from broadly representative demographic groups, including those who are at lower risk of skin cancer.
- In:
- Cancer
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News Streaming to discuss her reporting.
veryGood! (56)
Related
- Colorado police shot, kill mountain lion after animal roamed on school's campus
- Lupita Nyong'o hints at split from Selema Masekela: 'A season of heartbreak'
- California Gov. Gavin Newsom to make a one-day visit to Israel en route to China
- Desperate and disaffected, Argentines to vote whether upstart Milei leads them into the unknown
- US Diplomats Notch a Win on Climate Super Pollutants With Help From the Private Sector
- Mary Lou Retton's Daughter Details Scary Setback Amid Olympian’s Hospitalization
- Horoscopes Today, October 18, 2023
- How Southern Charm Addressed the Tragic Death of Olivia Flowers' Brother
- Judge sets date for 9/11 defendants to enter pleas, deepening battle over court’s independence
- Scorsese centers men and their violence once again in 'Killers of the Flower Moon'
Ranking
- Video ‘bares’ all: Insurers say bear that damaged luxury cars was actually a person in a costume
- Calum Scott thanks Phillies fans after 'Dancing On My Own' hits 1 billion streams
- Ukraine’s parliament advances bill seen as targeting Orthodox church with historic ties to Moscow
- Johnny Bananas Unpeels What Makes a Great Reality TV Villain—and Why He Loves Being One
- West Virginia governor-elect Morrisey to be sworn in mid-January
- Brooke Burke Sets the Record Straight on Those Derek Hough Affair Comments
- Maryland police officer suspended after arrest on Capitol riot charges
- Biden to deliver Oval Office address on Israel and Ukraine on Thursday
Recommendation
-
Study finds Wisconsin voters approved a record number of school referenda
-
Jax Taylor and Shake Chatterjee's Wild House of Villains Feud Explained
-
Rite Aid plans to close 154 stores after bankruptcy filing. See if your store is one of them
-
Marte hits walk-off single in ninth, D-backs beat Phillies 2-1 and close to 2-1 in NLCS
-
4 charged in Detroit street shooting that left 2 dead, 5 wounded
-
Hollywood’s actors strike is nearing its 100th day. Why hasn’t a deal been reached and what’s next?
-
Raiders QB Jimmy Garoppolo ruled out against Bears due to back injury, per reports
-
Ranking all 32 NFL teams' throwback and alternate uniforms as Eagles debut Kelly Green